Immune checkpoint inhibitor retreatment in second-line treatment of esophageal cancer: A real-world study.

被引：0
|
作者：
Kang, Yixin
Zhang, Dianbao
Mi, Youjia
Niu, Xiedong
Kang, Yuan
Xie, Dongjie
Li, Wenyao
Zhang, Ce
Yang, Junqiang
Yao, Jun
机构：
[1] Henan Univ Sci & Technol, Affiliated Hosp 1, Luoyang, Peoples R China
[2] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Gastroenterol Oncol, Luoyang, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16034
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Real-world outcomes upon second-line treatment in patients with chronic lymphocytic leukaemia
    Vainer, Noomi
    Aarup, Kathrine
    Andersen, Michael Asger
    Wind-Hansen, Lise
    Nielsen, Tine
    Frederiksen, Henrik
    Enggaard, Lisbeth
    Poulsen, Christian Bjorn
    Niemann, Carsten U.
    Rotbain, Emelie C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 (05) : 874 - 886
  • [22] The real-world data of immune-checkpoint inhibitor combination therapy for unresectable or metastatic esophageal cancer: a multi-institutional cohort study
    Sato, Sho
    Ssuzuki, Takashi
    Chinen, Takashi
    Yamaguchi, Hironori
    Suzuki, Yusuke
    Hokamura, Nobukazu
    Saze, Zenichiro
    Kono, Koji
    Takahashi, Keita
    Yano, Fumiaki
    Kunisaki, Chikara
    Kosaka, Takashi
    Endo, Itaru
    Ichikawa, Yasushi
    Miyawaki, Yutaka
    Sato, Hiroshi
    Shimada, Hideaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, : 994 - 1001
  • [23] Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
    Qu, Wang
    Liu, Zimin
    Chen, Xiaobing
    Liu, Bo
    Zhao, Yunbo
    Yan, Hao
    Qu, Xiujuan
    Li, Shengmian
    Zang, Aimin
    Sun, Yongkun
    Zhu, Liangjun
    Zhou, Aiping
    BMC CANCER, 2024, 24 (01)
  • [24] Regorafenib monotherapy or combined with an immune-checkpoint inhibitor as later-line treatment for metastatic colorectal cancer: a multicenter, real-world retrospective study in China
    Wang Qu
    Zimin Liu
    Xiaobing Chen
    Bo Liu
    YunBo Zhao
    Hao Yan
    Xiujuan Qu
    Shengmian Li
    Aimin Zang
    Yongkun Sun
    Liangjun Zhu
    Aiping Zhou
    BMC Cancer, 24
  • [25] Efficacy and safety of regorafenib alone or in combinations in the second-line setting for advanced hepatocellular carcinoma: A multicenter real-world study.
    Zhang, Wei
    Zhao, Yanrong
    Ma, Guixiang
    Zhang, Yu
    Guo, Yuan
    Chen, Zhong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [26] Efficacy and safety of second-line regorafenib after sorafenib or lenvatinib first line in patients with unresectable hepatocellular carcinoma: A real-world study.
    Xue, Feng
    Zhai, Jian
    Liu, Jianwei
    Fu, Zhigang
    Sun, Yanfu
    Ge, Ruiliang
    Bai, Shilei
    Li, Xiaowei
    Wang, Kui
    Qu, Zengqiang
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16125 - E16125
  • [27] First- and Second-Line Palliative Systemic Treatment Outcomes in a Real-World Metastatic Pancreatic Cancer Cohort
    Pijnappel, Esther N.
    Dijksterhuis, Willemieke P. M.
    van der Geest, Lydia G.
    de Vos-Geelen, Judith
    de Groot, Jan Willem B.
    Homs, Marjolein Y., V
    Creemers, Geert-jan
    Mohammad, Nadia Haj
    Besselink, Marc G.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (05): : 443 - +
  • [28] Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib
    Koutsoukos, Konstantinos
    Bamias, Aristotelis
    Tzannis, Kimon
    Espinosa Montano, Marta
    Bozionelou, Vasiliki
    Christodoulou, Christos
    Stefanou, Dimitra
    Kalofonos, Haralabos
    Duran, Ignacio
    Papazisis, Konstantinos
    ONCOTARGETS AND THERAPY, 2017, 10 : 4885 - 4893
  • [29] Primary pericardial mesothelioma: a case report of a patient treated with an immune checkpoint inhibitor as the second-line treatment
    Arponen, Otso
    Salo, Virpi
    Lonnberg, Annika
    Vaalavirta, Leila
    Koivu, Hannu
    Nyandoto, Paul
    ACTA ONCOLOGICA, 2021, 60 (05) : 687 - 691
  • [30] A real-world clinical study of camrelizumab in the treatment of esophageal cancer
    Sun, G.
    Peng, W.
    Wang, F.
    Cheng, H.
    Wang, S. Z.
    Xia, L.
    Du, Y.
    ANNALS OF ONCOLOGY, 2020, 31 : S1318 - S1318
12345